首页 > 最新文献

Journal of pharmacy and pharmacology research最新文献

英文 中文
The Impact of Media Exposure on Anxiety in Kuwait during COVID-19 Outbreak COVID-19爆发期间媒体暴露对科威特焦虑的影响
Pub Date : 2023-01-01 DOI: 10.26502/fjppr.072
Lulua Alasousi Sara al Hammouri, Sara al Al-abdulhadi, Ahmad T. Al-Sultan
,
{"title":"The Impact of Media Exposure on Anxiety in Kuwait during COVID-19 Outbreak","authors":"Lulua Alasousi Sara al Hammouri, Sara al Al-abdulhadi, Ahmad T. Al-Sultan","doi":"10.26502/fjppr.072","DOIUrl":"https://doi.org/10.26502/fjppr.072","url":null,"abstract":",","PeriodicalId":73897,"journal":{"name":"Journal of pharmacy and pharmacology research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69347639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends of Per-Patient Healthcare Cost and Resource Utilization of Opioid Use Disorder Among Privately Insured Individuals in The United States from 2005-2014 2005-2014年美国私人保险个体阿片类药物使用障碍的人均医疗成本和资源利用趋势
Pub Date : 2023-01-01 DOI: 10.26502/fjppr.084
Bibo Jiang, Li Wang, Douglas Leslie
{"title":"Trends of Per-Patient Healthcare Cost and Resource Utilization of Opioid Use Disorder Among Privately Insured Individuals in The United States from 2005-2014","authors":"Bibo Jiang, Li Wang, Douglas Leslie","doi":"10.26502/fjppr.084","DOIUrl":"https://doi.org/10.26502/fjppr.084","url":null,"abstract":"","PeriodicalId":73897,"journal":{"name":"Journal of pharmacy and pharmacology research","volume":"190 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134883147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Problem of Home Therapy during COVID-19 Pandemic in Italy: Government Guidelines versus Freedom of Cure? 意大利COVID-19大流行期间的家庭治疗问题:政府指导与治疗自由?
Pub Date : 2022-08-02 DOI: 10.26502/fjppr.055
Serafino Fazio, Marco Cosentino, Franca Marino, Sergio Pandolfi, Elisabetta Zanolin, Paolo Bellavite

After starting in late 2019, COVID-19 spread worldwide, and Italy was one of the first Western nations to be seriously affected. At that time, both the virus and the disease were little known and there were no Evidence-Based Medicine indications for treatment. The Italian Health Ministry guidelines claimed that, unless oxygen saturation fell to <92%, no pharmacological treatment was necessary during the first 72 hours, other than on a purely symptomatic basis, preferably with paracetamol. As later confirmed, that delay in therapeutic intervention may have been responsible for numerous hospital admissions and a very high lethality (3.5 %). To try to remedy this situation, several volunteer groups were formed, managing to promptlycure thousands of patients at home with non-steroidal anti-inflammatory drugs and a variety of re-purposed drugs (principally hydroxychloroquine, ivermectin) and supplements (such as antioxidants, polyphenols and vitamin D). Although not documented by any randomized controlled studies, these approaches were nonetheless based on the best available evidence, were aimed at addressing otherwise unmet major needs and produced a significant reduction of hospitalizations, of symptom duration, and a complete recovery from the disease compared with late treatment, according to some retrospective observational studies and the clinical experience of many physicians. A prompt discussion, with a clear and open exchange between healthcare Institutions and the said groups of voluntary physicians, could clarify the most effective approaches to reduce the number of hospitalizations and the lethality of this disease.

2019年底开始,COVID-19在全球蔓延,意大利是首批受到严重影响的西方国家之一。当时,人们对这种病毒和疾病都知之甚少,也没有治疗的循证医学指征。意大利卫生部的指导方针声称,除非血氧饱和度降到
{"title":"The Problem of Home Therapy during COVID-19 Pandemic in Italy: Government Guidelines versus Freedom of Cure?","authors":"Serafino Fazio,&nbsp;Marco Cosentino,&nbsp;Franca Marino,&nbsp;Sergio Pandolfi,&nbsp;Elisabetta Zanolin,&nbsp;Paolo Bellavite","doi":"10.26502/fjppr.055","DOIUrl":"https://doi.org/10.26502/fjppr.055","url":null,"abstract":"<p><p>After starting in late 2019, COVID-19 spread worldwide, and Italy was one of the first Western nations to be seriously affected. At that time, both the virus and the disease were little known and there were no Evidence-Based Medicine indications for treatment. The Italian Health Ministry guidelines claimed that, unless oxygen saturation fell to <92%, no pharmacological treatment was necessary during the first 72 hours, other than on a purely symptomatic basis, preferably with paracetamol. As later confirmed, that delay in therapeutic intervention may have been responsible for numerous hospital admissions and a very high lethality (3.5 %). To try to remedy this situation, several volunteer groups were formed, managing to promptlycure thousands of patients at home with non-steroidal anti-inflammatory drugs and a variety of re-purposed drugs (principally hydroxychloroquine, ivermectin) and supplements (such as antioxidants, polyphenols and vitamin D). Although not documented by any randomized controlled studies, these approaches were nonetheless based on the best available evidence, were aimed at addressing otherwise unmet major needs and produced a significant reduction of hospitalizations, of symptom duration, and a complete recovery from the disease compared with late treatment, according to some retrospective observational studies and the clinical experience of many physicians. A prompt discussion, with a clear and open exchange between healthcare Institutions and the said groups of voluntary physicians, could clarify the most effective approaches to reduce the number of hospitalizations and the lethality of this disease.</p>","PeriodicalId":73897,"journal":{"name":"Journal of pharmacy and pharmacology research","volume":"6 3","pages":"100-114"},"PeriodicalIF":0.0,"publicationDate":"2022-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9471922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Evaluate Effectiveness of Hubbard Purification Rundown Process for Victims of Dioxin/Agent Orange and Related Strengths, Challenges 评估哈伯德净化流程对二恶英/橙剂受害者的有效性及其相关优势和挑战
Pub Date : 2022-01-01 DOI: 10.26502/fjppr.056
Hoang Duc Hau, Tran Ngoc Tam
studies shown that dioxin, once pervades the can cause complicated damages at multiple sites, leading to several Current dioxin detoxification methods mainly address symptoms through integrated measures such as improving health with a diet rich in protein, vitamins, stimulating immunity, taking liver supplements to protect liver cells, or taking antioxidants in combination with steaming. Abstract Objective : The aim of this study was to assess the effectiveness of Hubbard purification rundown (PR) process for victims of agent orange in the centers of detoxification. Methods : The study was designed as a cross-sectional study combining quantitative and qualitative methods and carried out on 30 dioxin patients, 21 health workers, and 299 medical records in Hanoi and Da Nang centers for dioxin detoxification (CDD) of Vietnam. Results: A small number of patients were clinically examined before enrolling in and after finishing the treatment, 35%, and 0% respectively. In addition, 15% of patients did not finish their daily PR session in the second step, while 20% of them were not evaluated daily for treatment effectiveness in the fourth step by health workers. Furthermore, 20% of patients did not follow all 6 steps of
研究表明,二恶英一旦进入人体,会在多个部位造成复杂的损害,导致目前的几种二恶英解毒方法主要是通过综合措施来解决症状,如通过富含蛋白质和维生素的饮食改善健康,刺激免疫力,服用肝脏补充剂以保护肝细胞,或服用抗氧化剂结合蒸。摘要目的:本研究的目的是评估哈伯德净化流程(PR)对橙剂脱毒中心受害者的有效性。方法:采用定量与定性相结合的横断面研究方法,对越南河内市和岘港市二恶英脱毒中心的30名二恶英患者、21名卫生工作者和299份病历进行分析。结果:入组前和治疗结束后进行临床检查的患者数量较少,分别为35%和0%。此外,15%的患者在第二步中没有完成他们的日常PR会议,而20%的患者在第四步中没有得到卫生工作者对治疗效果的日常评估。此外,20%的患者没有遵循所有的6个步骤
{"title":"Evaluate Effectiveness of Hubbard Purification Rundown Process for Victims of Dioxin/Agent Orange and Related Strengths, Challenges","authors":"Hoang Duc Hau, Tran Ngoc Tam","doi":"10.26502/fjppr.056","DOIUrl":"https://doi.org/10.26502/fjppr.056","url":null,"abstract":"studies shown that dioxin, once pervades the can cause complicated damages at multiple sites, leading to several Current dioxin detoxification methods mainly address symptoms through integrated measures such as improving health with a diet rich in protein, vitamins, stimulating immunity, taking liver supplements to protect liver cells, or taking antioxidants in combination with steaming. Abstract Objective : The aim of this study was to assess the effectiveness of Hubbard purification rundown (PR) process for victims of agent orange in the centers of detoxification. Methods : The study was designed as a cross-sectional study combining quantitative and qualitative methods and carried out on 30 dioxin patients, 21 health workers, and 299 medical records in Hanoi and Da Nang centers for dioxin detoxification (CDD) of Vietnam. Results: A small number of patients were clinically examined before enrolling in and after finishing the treatment, 35%, and 0% respectively. In addition, 15% of patients did not finish their daily PR session in the second step, while 20% of them were not evaluated daily for treatment effectiveness in the fourth step by health workers. Furthermore, 20% of patients did not follow all 6 steps of","PeriodicalId":73897,"journal":{"name":"Journal of pharmacy and pharmacology research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69347427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatoprotective Effects of Dawa-Ul-Kurkum, a Unani Polyherbal Preparation and the Possible Mechanisms in Experimental Model of Ethanol Induced Liver Damage in Rats 乌兰尼多药制剂达瓦乌尔库姆的保肝作用及其在乙醇诱导大鼠肝损伤实验模型中的可能机制
Pub Date : 2022-01-01 DOI: 10.26502/fjppr.057
Mohd Rafi Reshi, K. Gulati, M. Naqvi, Nafaa Hassan, A. Ray
The liver is an important organ that is involved in metabolism, storage, secretion, and detoxification. Chronic alcohol misuse can cause hepatotoxicity, putting the liver's normal function in jeopardy. Hepatotoxicity caused by ethanol is primarily caused by toxic byproducts of its metabolism, which cause oxidative stress [1]. Alcohol is a psychoactive chemical that has been linked to a variety of health concerns around the world [2]. Oxidative stress is one of the key mechanisms of ethanol-induced hepatotoxicity. Alcohol dehydrogenase converts ethanol to acetaldehyde, which is then oxidized to acetate by acetaldehyde dehydrogenase [3-6]. When ethanol is taken in excess, it is converted mostly to acetaldehyde by the enzyme cytochrome P450 (CYP2E1), which is implicated in the production of reactive oxygen species (ROS) [7-9]. As a result, oxidative stress is caused by an increase in ROS combined with a reduction in antioxidant capability. Recent research suggests that ethanol-induced oxidative stress plays a key role in the development and progression of alcoholic liver disease [10-12]. Abstract
肝脏是参与代谢、储存、分泌和解毒的重要器官。长期酒精滥用会导致肝毒性,使肝脏的正常功能处于危险之中。乙醇引起的肝毒性主要是由其代谢的有毒副产物引起的,这些副产物引起氧化应激。酒精是一种精神活性化学物质,与世界各地的各种健康问题有关。氧化应激是乙醇肝毒性的重要机制之一。乙醇脱氢酶将乙醇转化为乙醛,然后乙醛脱氢酶将其氧化为乙酸[3-6]。当乙醇摄入过量时,它主要通过细胞色素P450 (CYP2E1)酶转化为乙醛,这与活性氧(ROS)的产生有关[7-9]。因此,氧化应激是由ROS的增加和抗氧化能力的降低引起的。最近的研究表明,乙醇诱导的氧化应激在酒精性肝病的发生和发展中起着关键作用[10-12]。摘要
{"title":"Hepatoprotective Effects of Dawa-Ul-Kurkum, a Unani Polyherbal Preparation and the Possible Mechanisms in Experimental Model of Ethanol Induced Liver Damage in Rats","authors":"Mohd Rafi Reshi, K. Gulati, M. Naqvi, Nafaa Hassan, A. Ray","doi":"10.26502/fjppr.057","DOIUrl":"https://doi.org/10.26502/fjppr.057","url":null,"abstract":"The liver is an important organ that is involved in metabolism, storage, secretion, and detoxification. Chronic alcohol misuse can cause hepatotoxicity, putting the liver's normal function in jeopardy. Hepatotoxicity caused by ethanol is primarily caused by toxic byproducts of its metabolism, which cause oxidative stress [1]. Alcohol is a psychoactive chemical that has been linked to a variety of health concerns around the world [2]. Oxidative stress is one of the key mechanisms of ethanol-induced hepatotoxicity. Alcohol dehydrogenase converts ethanol to acetaldehyde, which is then oxidized to acetate by acetaldehyde dehydrogenase [3-6]. When ethanol is taken in excess, it is converted mostly to acetaldehyde by the enzyme cytochrome P450 (CYP2E1), which is implicated in the production of reactive oxygen species (ROS) [7-9]. As a result, oxidative stress is caused by an increase in ROS combined with a reduction in antioxidant capability. Recent research suggests that ethanol-induced oxidative stress plays a key role in the development and progression of alcoholic liver disease [10-12]. Abstract","PeriodicalId":73897,"journal":{"name":"Journal of pharmacy and pharmacology research","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69347434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Relationship between High Absolute Lymphocyte Counts and Favorable Prognosis in Eribulin Therapy is seen in First-Line Chemotherapy for Metastatic Breast Cancer: Combined Analysis of Two Phase 2 Studies 转移性乳腺癌一线化疗中,高绝对淋巴细胞计数与良好预后的关系:两项2期研究的综合分析
Pub Date : 2022-01-01 DOI: 10.26502/fjppr.059
K. Kimura, T. Takashima, Hiroyo Oku, Ayana Ikari, Tomo Tominaga, Saki Takai, Junna Sakane, Michiaki Tanaka, H. Kawajiri, S. Kashiwagi, S. Tokunaga, S. Nishimura, S. Noda, M. Iwamoto
Iwamoto. The Relationship between High Absolute Lymphocyte Counts and Favorable Prognosis in Eribulin Therapy is seen in First-Line Chemotherapy for Metastatic Breast Cancer: Combined Analysis of Two Phase 2 Studies. Journal of Pharmacy and Pharmacology Research 6 (2022): 139-146. Abstract Background: While absolute lymphocyte count (ALC) and neutrophil-to-lymphocyte ratio (NLR) are associated with prolonged progression-free survival (PFS) and overall survival (OS), the influence of previous chemotherapy on blood cell counts may necessitate an evaluation of baseline ALC and NLR in first-line chemotherapy patients. Methods: Patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) who received first-line eribulin chemotherapy in two phase 2 trials (BIRICHEN and OMC-BC 03) were retrospectively analyzed. HER2-negative MBC patients who received first-line chemotherapy other than eribulin (treatment of physician’s choice; TPC) at Osaka Medical and Pharmaceutical University Hospital between March 2013 and March 2017 were also analyzed for comparison. Results: In the eribulin group, the median OS (mOS) was 30.9 and 17.8 months in the high-(H-)ALC (≥1500/μL; n = 33) and low-(L-)ALC (<1500/ μL; n = 26) groups, respectively (hazard ratio [HR], 0.52; 95% confidence interval [CI]: 0.27–1.01), whereas it was 30.9 and 15.4 months in the L-NLR (<2.5; n = 23) and H-NLR (≥2.5; n = 36) groups, respectively (HR, 0.49; 95% CI: 0.25–0.95). In the TPC group, neither ALC nor NLR was associated with OS or PFS extension. The Relationship between High Absolute Lymphocyte Counts and Favorable Prognosis in Eribulin Therapy is seen in First-Line Chemotherapy for Metastatic Breast Cancer: Combined Analysis of Two Phase 2 Studies. Journal of Pharmacy and Pharmacology Research 6 (2022):
Iwamoto。转移性乳腺癌一线化疗中,高绝对淋巴细胞计数与良好预后的关系:两项2期研究的综合分析药学与药理学研究6(2022):139-146。背景:虽然绝对淋巴细胞计数(ALC)和中性粒细胞与淋巴细胞比率(NLR)与延长无进展生存期(PFS)和总生存期(OS)相关,但既往化疗对血细胞计数的影响可能需要评估一线化疗患者的基线ALC和NLR。方法:回顾性分析两项2期临床试验(BIRICHEN和OMC-BC 03)中接受伊立布林一线化疗的人表皮生长因子受体2 (HER2)阴性转移性乳腺癌(MBC)患者。her2阴性MBC患者接受一线化疗而非依瑞布林(医生选择的治疗方案);2013年3月至2017年3月,大阪医科大学附属医院的TPC患者也进行了比较分析。结果:在高(H)ALC(≥1500/μL)组中位OS (mOS)为30.9和17.8个月;n = 33)和低(L-)ALC (<1500/ μL;n = 26)组(风险比[HR], 0.52;95%可信区间[CI]: 0.27-1.01),而L-NLR分别为30.9个月和15.4个月(<2.5;n = 23)和H-NLR(≥2.5;n = 36)组(HR, 0.49;95% ci: 0.25-0.95)。在TPC组中,ALC和NLR均与OS或PFS扩展无关。转移性乳腺癌一线化疗中,高绝对淋巴细胞计数与良好预后的关系:两项2期研究的综合分析药学与药理学研究6 (2022):
{"title":"The Relationship between High Absolute Lymphocyte Counts and Favorable Prognosis in Eribulin Therapy is seen in First-Line Chemotherapy for Metastatic Breast Cancer: Combined Analysis of Two Phase 2 Studies","authors":"K. Kimura, T. Takashima, Hiroyo Oku, Ayana Ikari, Tomo Tominaga, Saki Takai, Junna Sakane, Michiaki Tanaka, H. Kawajiri, S. Kashiwagi, S. Tokunaga, S. Nishimura, S. Noda, M. Iwamoto","doi":"10.26502/fjppr.059","DOIUrl":"https://doi.org/10.26502/fjppr.059","url":null,"abstract":"Iwamoto. The Relationship between High Absolute Lymphocyte Counts and Favorable Prognosis in Eribulin Therapy is seen in First-Line Chemotherapy for Metastatic Breast Cancer: Combined Analysis of Two Phase 2 Studies. Journal of Pharmacy and Pharmacology Research 6 (2022): 139-146. Abstract Background: While absolute lymphocyte count (ALC) and neutrophil-to-lymphocyte ratio (NLR) are associated with prolonged progression-free survival (PFS) and overall survival (OS), the influence of previous chemotherapy on blood cell counts may necessitate an evaluation of baseline ALC and NLR in first-line chemotherapy patients. Methods: Patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) who received first-line eribulin chemotherapy in two phase 2 trials (BIRICHEN and OMC-BC 03) were retrospectively analyzed. HER2-negative MBC patients who received first-line chemotherapy other than eribulin (treatment of physician’s choice; TPC) at Osaka Medical and Pharmaceutical University Hospital between March 2013 and March 2017 were also analyzed for comparison. Results: In the eribulin group, the median OS (mOS) was 30.9 and 17.8 months in the high-(H-)ALC (≥1500/μL; n = 33) and low-(L-)ALC (<1500/ μL; n = 26) groups, respectively (hazard ratio [HR], 0.52; 95% confidence interval [CI]: 0.27–1.01), whereas it was 30.9 and 15.4 months in the L-NLR (<2.5; n = 23) and H-NLR (≥2.5; n = 36) groups, respectively (HR, 0.49; 95% CI: 0.25–0.95). In the TPC group, neither ALC nor NLR was associated with OS or PFS extension. The Relationship between High Absolute Lymphocyte Counts and Favorable Prognosis in Eribulin Therapy is seen in First-Line Chemotherapy for Metastatic Breast Cancer: Combined Analysis of Two Phase 2 Studies. Journal of Pharmacy and Pharmacology Research 6 (2022):","PeriodicalId":73897,"journal":{"name":"Journal of pharmacy and pharmacology research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69347481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tragic Choices, Government Actions and the ‘domino effect’ the Case of the COVID - 19 Syndemic and the Italian scenario 悲剧性选择、政府行动和“多米诺骨牌效应”:COVID - 19疫情和意大利的情况
Pub Date : 2022-01-01 DOI: 10.26502/jppr.0048
Matteo Maria Cati
{"title":"Tragic Choices, Government Actions and the ‘domino effect’ the Case of the COVID - 19 Syndemic and the Italian scenario","authors":"Matteo Maria Cati","doi":"10.26502/jppr.0048","DOIUrl":"https://doi.org/10.26502/jppr.0048","url":null,"abstract":"","PeriodicalId":73897,"journal":{"name":"Journal of pharmacy and pharmacology research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69351365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Edible Green Solvent for Optimized Catechins Extraction from Green Tea Leaves: Anti-Hypercholesterolemia. 从绿茶中提取儿茶素的最佳食用绿色溶剂:抗高胆固醇血症。
Pub Date : 2022-01-01 Epub Date: 2022-06-29 DOI: 10.26502/fjppr.053
Kazutoshi Fujioka, Taher A Salaheldin, Kavitha Godugu, Harold V Meyers, Shaker A Mousa

Catechin polyphenols are the major bioactive ingredients in green tea with various human health benefits. Extraction of catechins from green tea (GTE) leaves at optimized standard conditions is still a challenging approach. An optimized, rapid, and economic extraction method is industrially needed. We hypothesized that certain extraction techniques in the presence of natural polymers and antioxidants might improve GTE catechin extraction yield and its biological activity. The effect of microwave (30-60 seconds irradiation in a typical kitchen microwave) assisted extraction (MAE) and ultrasonic assisted extraction (UAE) techniques were evaluated separately and in combination. To study the effect of the extraction solvent, nine edible green solvent combinations were investigated namely water, ascorbic acid, chitosan/ascorbic acid, carboxymethylcellulose /ascorbic acid, methylcellulose /ascorbic acid, chitosan/methylcellulose/ascorbic acid, methylcellulose, chitosan/acetic acid, and ethanol. The amounts of extracted catechins from green tea leaves were quantified with HPLC-UV. Data showed that the use of MAE & UAE technique was the optimal in producing a higher extraction yield of catechins. Chitosan/ascorbic acid was the optimized solvent with high extraction efficiencies of catechins. Studies in high fat diet fed animals demonstrated significant reduction of total cholesterol and LDL-C by GTE after 3 weeks of oral daily administration. In conclusion, efficient extraction, and stabilization of catechins from green tea leaves demonstrated a significant lowering of high fat diet-mediated elevation in blood cholesterol and LDL-C levels.

儿茶素多酚是绿茶中的主要生物活性成分,对人体健康有多种益处。在最佳标准条件下从绿茶叶中提取儿茶素仍然是一个具有挑战性的方法。工业上需要一种优化、快速、经济的提取方法。我们假设在天然聚合物和抗氧化剂存在的情况下,某些提取技术可能提高GTE儿茶素的提取率和生物活性。研究了微波辅助提取(MAE)和超声辅助提取(UAE)两种技术的效果。以水、抗坏血酸、壳聚糖/抗坏血酸、羧甲基纤维素/抗坏血酸、甲基纤维素/抗坏血酸、壳聚糖/甲基纤维素/抗坏血酸、甲基纤维素/抗坏血酸、壳聚糖/甲基纤维素/抗坏血酸、甲基纤维素、壳聚糖/乙酸、乙醇等9种可食用绿色溶剂组合为研究对象,研究了提取溶剂的效果。采用高效液相色谱-紫外分光光度法测定绿茶中儿茶素的含量。实验结果表明,采用MAE - UAE工艺提取儿茶素提取率最高。壳聚糖/抗坏血酸是提取儿茶素效率最高的最佳溶剂。对高脂肪饲料喂养的动物的研究表明,每日口服三周后,GTE显著降低了总胆固醇和LDL-C。综上所述,绿茶中儿茶素的有效提取和稳定证明了高脂肪饮食引起的血液胆固醇和LDL-C水平升高的显著降低。
{"title":"Edible Green Solvent for Optimized Catechins Extraction from Green Tea Leaves: Anti-Hypercholesterolemia.","authors":"Kazutoshi Fujioka,&nbsp;Taher A Salaheldin,&nbsp;Kavitha Godugu,&nbsp;Harold V Meyers,&nbsp;Shaker A Mousa","doi":"10.26502/fjppr.053","DOIUrl":"https://doi.org/10.26502/fjppr.053","url":null,"abstract":"<p><p>Catechin polyphenols are the major bioactive ingredients in green tea with various human health benefits. Extraction of catechins from green tea (GTE) leaves at optimized standard conditions is still a challenging approach. An optimized, rapid, and economic extraction method is industrially needed. We hypothesized that certain extraction techniques in the presence of natural polymers and antioxidants might improve GTE catechin extraction yield and its biological activity. The effect of microwave (30-60 seconds irradiation in a typical kitchen microwave) assisted extraction (MAE) and ultrasonic assisted extraction (UAE) techniques were evaluated separately and in combination. To study the effect of the extraction solvent, nine edible green solvent combinations were investigated namely water, ascorbic acid, chitosan/ascorbic acid, carboxymethylcellulose /ascorbic acid, methylcellulose /ascorbic acid, chitosan/methylcellulose/ascorbic acid, methylcellulose, chitosan/acetic acid, and ethanol. The amounts of extracted catechins from green tea leaves were quantified with HPLC-UV. Data showed that the use of MAE & UAE technique was the optimal in producing a higher extraction yield of catechins. Chitosan/ascorbic acid was the optimized solvent with high extraction efficiencies of catechins. Studies in high fat diet fed animals demonstrated significant reduction of total cholesterol and LDL-C by GTE after 3 weeks of oral daily administration. In conclusion, efficient extraction, and stabilization of catechins from green tea leaves demonstrated a significant lowering of high fat diet-mediated elevation in blood cholesterol and LDL-C levels.</p>","PeriodicalId":73897,"journal":{"name":"Journal of pharmacy and pharmacology research","volume":"6 2","pages":"80-92"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40557708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Determination of Meropenem, Ceftazidime and Piperacillin Levels in Serum and Meropenem in Cerebrospinal Fluid by Liquid Chromatography for Routine Quantification 液相色谱法测定血清中美罗培南、头孢他啶、哌拉西林及脑脊液中美罗培南的常规定量
Pub Date : 2022-01-01 DOI: 10.26502/fjppr.062
Stefan Günther, A. Reimer, H. Vogl, Stephan Spenke, Hanns-Christian Dinges, A. Schubert, Leopold Hj Eberhart, G. Geldner
((4R,5S,6S)-3-[[(3S,5S)-5-[(Dimethylamino)carbonyl]-3-Abstract Objective: Therapeutic drug monitoring (TDM) of β-lactam antibiotics is a commonly used to prevent treatment failures in critically ill patients. A quick and simple high-performance liquid chromatography (HPLC) assay for the determination of meropenem, ceftazidime and piperacillin in human serum and meopenem in
[(4R,5S,6S)-3-[[(3S,5S)-5-[(二甲氨基)羰基]-3]摘要目的:β-内酰胺类抗生素的治疗性药物监测(TDM)是预防危重患者治疗失败的常用手段。建立了快速简便的高效液相色谱法测定人血清中美罗培南、头孢他啶和哌拉西林的含量
{"title":"Determination of Meropenem, Ceftazidime and Piperacillin Levels in Serum and Meropenem in Cerebrospinal Fluid by Liquid Chromatography for Routine Quantification","authors":"Stefan Günther, A. Reimer, H. Vogl, Stephan Spenke, Hanns-Christian Dinges, A. Schubert, Leopold Hj Eberhart, G. Geldner","doi":"10.26502/fjppr.062","DOIUrl":"https://doi.org/10.26502/fjppr.062","url":null,"abstract":"((4R,5S,6S)-3-[[(3S,5S)-5-[(Dimethylamino)carbonyl]-3-Abstract Objective: Therapeutic drug monitoring (TDM) of β-lactam antibiotics is a commonly used to prevent treatment failures in critically ill patients. A quick and simple high-performance liquid chromatography (HPLC) assay for the determination of meropenem, ceftazidime and piperacillin in human serum and meopenem in","PeriodicalId":73897,"journal":{"name":"Journal of pharmacy and pharmacology research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69347495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Age-Dependent Heterogeneity of Lymph Node Metastases and Survival Identified by Analysis of a National Breast Cancer Registry. 通过分析全国乳腺癌登记册发现淋巴结转移和生存率的年龄异质性
Pub Date : 2022-01-01 Epub Date: 2022-09-19 DOI: 10.26502/fjppr.060
Michael Behring, Prachi Bajpai, Farrukh Afaq, Amr Elkholy, Hyung-Gyoon Kim, Sameer Al Diffalha, Sadeep Shrestha, Upender Manne

Background: For several cancers, including those of the breast, young age at diagnosis is associated with an adverse prognosis. Although this effect is often attributed to heritable mutations such as BRCA1/2, the relationship between pathologic features, young age of onset, and prognosis for breast cancer remains unclear. In the present study, we highlight links between age of onset and lymph node metastasis (NM) in US women with breast cancer.

Methods: Case listings from Surveillance, Epidemiology, and End Result (SEER) 18 registry data for women with breast cancer, which include information on race, were used. NM and its associated outcomes were evaluated for a subset of women with receptor subtype information and then compared against a larger, pre-subtype validation set of data from the same registry. Age of diagnosis was a 5-category variable; under 40 years, 40-49 years, 50-59 years, 60-69 years and 70+ years. Univariate and adjusted multivariate survival models were applied to both sets of data.

Results: As determined with adjusted logistic regression models, women under 40 years old at diagnosis had 1.55 times the odds of NM as women 60-69 years of age. The odds of NM for (HR = hormone receptor) HR+/HER2+, HR-/HER2+, and triple-negative breast cancer subtypes were significantly lower than those for HR+/HER2-. In subtype-stratified adjusted models, age of diagnosis had a consistent trend of decreasing odds of NM by age category, most noticeable for HR+ subtypes of luminal A and B. Univariate 5-year survival by age was worst for women under 40 years, with NM attributable for 49% of the hazard of death from cancer in adjusted multivariate models.

Conclusions: Lymph node metastasis is age-dependent, yet not all molecular subtypes are clearly affected by this relationship. For <40-yr-old women, NM is a major cause for shorter survival. When stratified by subtype, the strongest associations were in HR+ groups, suggesting a possible hormonal connection between young age of breast cancer onset and NM.

背景:对于包括乳腺癌在内的多种癌症而言,年轻的诊断年龄与不良预后有关。虽然这种影响通常归因于遗传突变,如 BRCA1/2,但乳腺癌的病理特征、年轻发病年龄和预后之间的关系仍不清楚。在本研究中,我们强调了美国女性乳腺癌患者的发病年龄与淋巴结转移(NM)之间的联系:方法:我们使用了监测、流行病学和最终结果(SEER)18 登记数据中的病例列表,这些数据包括乳腺癌女性患者的种族信息。对包含受体亚型信息的妇女子集的 NM 及其相关结果进行了评估,然后与来自同一登记处的更大的、亚型前验证数据集进行了比较。诊断年龄分为五类:40 岁以下、40-49 岁、50-59 岁、60-69 岁和 70 岁以上。对两组数据均采用了单变量和调整后多变量生存模型:根据调整后的逻辑回归模型,确诊时年龄在 40 岁以下的女性患 NM 的几率是 60-69 岁女性的 1.55 倍。HR=激素受体)HR+/HER2+、HR-/HER2+和三阴性乳腺癌亚型的NM几率明显低于HR+/HER2-。在亚型分层调整模型中,确诊年龄呈逐年降低淋巴结转移几率的趋势,其中以HR+亚型管腔A型和B型最为明显。40岁以下女性的单变量5年生存率最差,在调整后的多变量模型中,淋巴结转移占癌症死亡危险的49%:结论:淋巴结转移与年龄有关,但并非所有分子亚型都受到这种关系的明显影响。对于
{"title":"Age-Dependent Heterogeneity of Lymph Node Metastases and Survival Identified by Analysis of a National Breast Cancer Registry.","authors":"Michael Behring, Prachi Bajpai, Farrukh Afaq, Amr Elkholy, Hyung-Gyoon Kim, Sameer Al Diffalha, Sadeep Shrestha, Upender Manne","doi":"10.26502/fjppr.060","DOIUrl":"10.26502/fjppr.060","url":null,"abstract":"<p><strong>Background: </strong>For several cancers, including those of the breast, young age at diagnosis is associated with an adverse prognosis. Although this effect is often attributed to heritable mutations such as BRCA1/2, the relationship between pathologic features, young age of onset, and prognosis for breast cancer remains unclear. In the present study, we highlight links between age of onset and lymph node metastasis (NM) in US women with breast cancer.</p><p><strong>Methods: </strong>Case listings from Surveillance, Epidemiology, and End Result (SEER) 18 registry data for women with breast cancer, which include information on race, were used. NM and its associated outcomes were evaluated for a subset of women with receptor subtype information and then compared against a larger, pre-subtype validation set of data from the same registry. Age of diagnosis was a 5-category variable; under 40 years, 40-49 years, 50-59 years, 60-69 years and 70+ years. Univariate and adjusted multivariate survival models were applied to both sets of data.</p><p><strong>Results: </strong>As determined with adjusted logistic regression models, women under 40 years old at diagnosis had 1.55 times the odds of NM as women 60-69 years of age. The odds of NM for (HR = hormone receptor) HR+/HER2+, HR-/HER2+, and triple-negative breast cancer subtypes were significantly lower than those for HR+/HER2-. In subtype-stratified adjusted models, age of diagnosis had a consistent trend of decreasing odds of NM by age category, most noticeable for HR+ subtypes of luminal A and B. Univariate 5-year survival by age was worst for women under 40 years, with NM attributable for 49% of the hazard of death from cancer in adjusted multivariate models.</p><p><strong>Conclusions: </strong>Lymph node metastasis is age-dependent, yet not all molecular subtypes are clearly affected by this relationship. For <40-yr-old women, NM is a major cause for shorter survival. When stratified by subtype, the strongest associations were in HR+ groups, suggesting a possible hormonal connection between young age of breast cancer onset and NM.</p>","PeriodicalId":73897,"journal":{"name":"Journal of pharmacy and pharmacology research","volume":" ","pages":"147-157"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601600/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40651826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of pharmacy and pharmacology research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1